Gunesli, Gozde N.
Bilal, Mohsin
Raza, Shan E Ahmed
Rajpoot, Nasir M.
Article History
Received: 6 June 2023
Accepted: 7 September 2023
First Online: 16 September 2023
Declarations
:
: NR is a Director and CSO of Histofy Ltd. NR declares that he is in receipt of research funding from AstraZeneca and GlaxoSmithKline (GSK) and is also a GSK Chair of Computational Pathology at the University of Warwick, UK. All other authors declare no competing interests.